Saliva COVID-19 Tests Offer Way Around Nasopharyngeal Swab Shortage Bottlenecks by Glenn S. Demby | Sep 4, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.RegisterAlready a member? Log in here
UK Antibodies Prevalence Study Suggests that Minorities Contract COVID-19 at Disproportionately Higher Rates by Glenn S. Demby | Sep 3, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.RegisterAlready a member? Log in here
Major Insurer Claims It Has No Obligation to Pay for Pooled COVID-19 Testing by Glenn S. Demby | Sep 3, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Reimbursement-dtet, The Business of Testing-dtet, Top of the News-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
HHS Clears the Way for Use of New COVID-19 Tests without FDA Emergency Use Authorization by Glenn S. Demby | Aug 29, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings by Glenn S. Demby | Aug 20, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir... This content is for Paid Members only.RegisterAlready a member? Log in here